Accounts Receivable, after Allowance for Credit Loss, Current in USD of CollPlant Biotechnologies Ltd from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
CollPlant Biotechnologies Ltd quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2019 to Q4 2024.
  • CollPlant Biotechnologies Ltd Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2024 was $150,000.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

CollPlant Biotechnologies Ltd Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $150,000 31 Dec 2024 6-K 20 Aug 2025
Q2 2024 $250,000 30 Jun 2024 6-K 20 Aug 2024 2024 Q2
Q4 2022 $9,000 -$261,000 -97% 31 Dec 2022 20-F 04 Apr 2024 2023 FY
Q2 2022 $9,000 -$268,000 -97% 30 Jun 2022 6-K 25 Aug 2022 2022 Q2
Q4 2021 $270,000 -$560,000 -67% 31 Dec 2021 20-F 29 Mar 2023 2022 FY
Q2 2021 $277,000 30 Jun 2021 6-K 19 Aug 2021 2021 Q2
Q4 2020 $830,000 +$751,000 +951% 31 Dec 2020 20-F 24 Mar 2022 2021 FY
Q4 2019 $79,000 31 Dec 2019 20-F 26 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.